Skip to main content

Advertisement

Log in

HPV Vaccine Experiences and Preferences Among Young Adult Cancer Survivors and Caregivers of Childhood Cancer Survivors

  • Published:
Journal of Cancer Education Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

Cancer survivors are at higher risk of developing HPV-associated cancers later in life, yet their HPV vaccination rates remain lower than the general population. Improving HPV vaccination uptake among survivors is essential to preventing second malignancies. We interviewed HPV vaccine eligible adolescent and young adult (AYA) cancer survivors (18–26 years) and caregivers of HPV vaccine eligible childhood cancer survivors approaching the AYA age range (9–17 years) about their HPV vaccine experiences and preferences as informed by the HPV Vaccination Roundtable Best Practices. Interviews (N = 20) were recorded, transcribed, and analyzed using interpretive description. Of AYA survivors (n = 10), 50% had received at least one HPV vaccine dose. Of caregivers (n = 10), 30% reported their child had received at least one HPV vaccine dose. Three distinct categories emerged including (1) HPV vaccine knowledge, (2) HPV vaccination recommendation preferences, and (3) HPV vaccination reminder preferences. The first two categories were oncology focused. Participants lacked knowledge regarding HPV vaccine safety and applicability due to their complex cancer history. Most participants strongly preferred that their oncologist provide an HPV vaccine recommendation. The third category was mixed, with some participants preferring oncology-based HPV vaccine reminders while others preferred primary care-based reminders. Almost all participants preferred digital reminders (e.g., text messages). Our results suggest that oncologists play an essential role in recommending the HPV vaccine and providing information to assist survivors and caregivers with vaccine decision-making. Additionally, HPV vaccination uptake among pediatric and childhood and AYA survivors could be improved through the use of tailored, electronically delivered vaccine reminders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Data Availability

Not applicable.

References

  1. Bhatia S, Sklar C (2002) Second cancers in survivors of childhood cancer. Nat Rev Cancer 2(2):124–132. https://doi.org/10.1038/nrc722

    Article  PubMed  Google Scholar 

  2. Huang SF, Li HF, Liao CT, Wang HM, Chen IH, Chang J-C, Chen YJ, Cheng AJ (2012) Association of HPV infections with second primary tumors in early-staged oral cavity cancer. Oral Dis 18(8):809–815. https://doi.org/10.1111/j.1601-0825.2012.01950.x

    Article  CAS  PubMed  Google Scholar 

  3. Ojha RP, Tota JE, Offutt-Powell TN, Klosky JL, Minniear TD, Jackson BE, Gurney JG (2013) Human papillomavirus-associated subsequent malignancies among long-term survivors of pediatric and young adult cancers. PLoS One 8(8):e70349. https://doi.org/10.1371/journal.pone.0070349

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Satterwhite CL, Torrone E, Meites E, Dunne EF, Mahajan R, Ocfemia MCB, Su J, Xu F, Weinstock H (2013) Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008. Sex Transm Dis 40(3):187–193. https://doi.org/10.1097/OLQ.0b013e318286bb53

    Article  PubMed  Google Scholar 

  5. Joura EA, Pils S (2016) Vaccines against human papillomavirus infections: protection against cancer, genital warts or both? Clin Microbiol Infect 22:S125–S127. https://doi.org/10.1016/j.cmi.2016.12.017

    Article  PubMed  Google Scholar 

  6. Klosky JL, Hudson MM, Chen Y, Connelly JA, Wasilewski-Masker K, Sun CL, Francisco L, Gustafson L, Russell KM, Sabbatini G, Flynn JS, York JM, Giuliano AR, Robison LL, Wong FL, Bhatia S, Landier W (2017) Human papillomavirus vaccination rates in young cancer survivors. J Clin Oncol 35(13):3582–3590. https://doi.org/10.1200/JCO.2017.74.1843

    Article  PubMed  PubMed Central  Google Scholar 

  7. Ramsay JM, Mann K, Kaul S, Zamora ER, Smits-Seemann RR, Kirchhoff AC (2018) Follow-up care provider preferences of adolescent and young adult cancer survivors. J Adolesc Young Adult Oncol 7:204–209. https://doi.org/10.1089/jayao.2017.0083

    Article  PubMed  PubMed Central  Google Scholar 

  8. Castellino SM, Allen KE, Pleasant K, Keyes G, Poehling KA, Tooze JA (2019) Suboptimal uptake of human papillomavirus (HPV) vaccine in survivors of childhood and adolescent and young adult (AYA) cancer. J Cancer Surviv 13:730–738. https://doi.org/10.1007/s11764-019-00791-9

    Article  PubMed  PubMed Central  Google Scholar 

  9. Brewer NT, Hall ME, Malo TL, Gilkey MB, Quinn B, Lathren C (2017) Announcements versus conversations to improve HPV vaccination coverage: a randomized trial. Pediatrics 139(1):e20161764. https://doi.org/10.1542/peds.2016-1764

    Article  PubMed  PubMed Central  Google Scholar 

  10. American Academy of Family Physicians (2018) Human papillomavirus vaccine (HPV). American Academy of Family Physicians. https://www.aafp.org/patient-care/public-health/immunizations/disease-population/hpv.html.

  11. Centers for Disease Control and Prevention (2017) Speaking about HPV vaccine to your colleagues. Centers for Disease Control and Prevention. https://www.cdc.gov/hpv/hcp/speaking-colleagues.html

    Google Scholar 

  12. York JM, Klosky JL, Chen Y, Connelly JA, Wasilewski-Masker K, Giuliano A, Robison LL, Wong FL, Hudson MM, Bhatia S, Landier W (2018) Patient-level predictors of lack of healthcare provider recommendation for human papillomavirus (HPV) vaccination as reported by childhood cancer survivors and their families. J Clin Oncol 36(15_suppl):10514. https://doi.org/10.1200/JCO.2018.36.15_suppl.10514

    Article  Google Scholar 

  13. Kirchhoff AC, Mann K, Warner EL, Kaddas HK, Fair D, Fluchel M, Knackstedt ED, Kepka D (2019) HPV vaccination knowledge, intentions, and practices among caregivers of childhood cancer survivors. Hum Vaccin Immunother 15(7-8):1767–1775. https://doi.org/10.1080/21645515.2019.1619407

    Article  PubMed  PubMed Central  Google Scholar 

  14. Bae J, Ford EW, Wu S, Huerta T (2017) Electronic reminder's role in promoting human papillomavirus vaccine use. Am J Manag Care 23(11):e353–e359

    PubMed  Google Scholar 

  15. American Academy of Pediatrics (2018) Reminder & Recall Systems. American Academy of Pediatrics. https://www.aap.org/en-us/advocacy-and-policy/aap-health-initiatives/immunizations/Practice-Management/Pages/reminder-recall-systems.aspx. Accessed 11/10/2020

  16. Community preventive services task force increasing appropriate vaccination: standing orders. https://www.thecommunityguide.org/sites/default/files/assets/Vaccination-Standing-Orders.pdf. Accessed 5/23/2018

  17. Creswell JW, Poth CN (2018) Qualitative inquiry & research design: choosing among five approaches, 4th edn. Sage, Thousands Oaks

    Google Scholar 

  18. Thorne S, Kirkham SR, O'Flynn-Magee K (2004) The analytic challenge in interpretive description. Int J Qual Methods 3(1):1–11. https://doi.org/10.1177/160940690400300101

    Article  Google Scholar 

  19. Saldaña J (2013) The coding manual for qualitative researchers, 2nd edn. SAGE Publications Ltd, Los Angeles

    Google Scholar 

  20. McHugh ML (2012) Interrater reliability: the kappa statistic. Biochem Med 22(3):276–282

    Article  Google Scholar 

  21. Ylitalo KR, Lee H, Mehta NK (2013) Health care provider recommendation, human papillomavirus vaccination, and race/ethnicity in the US National Immunization Survey. Am J Public Health 103(1):164–169. https://doi.org/10.2105/AJPH.2011.300600

    Article  PubMed  PubMed Central  Google Scholar 

  22. Rosenthala SL, Weiss TW, Zimet GD, Ma L, Good MB, Vichninb MD (2011) Predictors of HPV vaccine uptake among women aged 19–26: importance of a physician's recommendation. Elsevier Vaccin 29(5):892–895. https://doi.org/10.1016/j.vaccine.2009.12.063

    Article  Google Scholar 

  23. Holman DM, Benard V, Roland KB, Watson M, Liddon N, Stokley S (2014) Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pediatr 168(1):76–82. https://doi.org/10.1001/jamapediatrics.2013.2752

    Article  PubMed  PubMed Central  Google Scholar 

  24. Harvey AM, Thompson S, Lac A, Coolidge FL (2019) Fear and derision: a quantitative content analysis of provaccine and antivaccine internet memes. Health Educ Behav 46(6):1012–1023. https://doi.org/10.1177/1090198119866886

    Article  PubMed  Google Scholar 

  25. Whitney CG, Zhou F, Singleton J, Schuchat A, Centers for Disease C, Prevention (2014) Benefits from immunization during the vaccines for children program era - United States, 1994-2013. MMWR Morb Mortal Wkly Rep 63(16):352–355

    PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This study would not have been completed without the contributions from the survivors and caregivers. The authors appreciate recruitment support from the Huntsman-Intermountain Adolescent and Young Adult (HIAYA) Program patient navigators as well as content feedback from the HIAYA Patient and Family Advisory Board.

Code Availability

Not applicable.

Funding

The research reported in this publication was supported by the St. Baldrick’s Foundation, Huntsman Cancer Foundation, and the National Cancer Institute of the National Institutes of Health under award numbers P30CA042014 and R03CA216174 (Kirchhoff and Kepka, PIs). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by Austin R. Waters, Karely Mann, and Perla L. Vaca Lopez. The first draft of the manuscript was written by Austin R. Waters, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Austin R. Waters.

Ethics declarations

Ethics Approval

All study materials and procedures were approved by the University of Utah IRB (IRB# 00113603).

Consent to Participate

Informed consent was obtained from all participants prior to participation in the interview.

Consent for Publication

Not applicable—deidentified data.

Conflict of Interest

Deanna Kepka receives a portion of her salary from American Cancer Society, which receives funding from Merck, for the purpose of Mission: HPV Cancer Free Quality Improvement Initiative.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Waters, A.R., Mann, K., Vaca Lopez, P.L. et al. HPV Vaccine Experiences and Preferences Among Young Adult Cancer Survivors and Caregivers of Childhood Cancer Survivors. J Canc Educ 37, 1519–1524 (2022). https://doi.org/10.1007/s13187-021-01992-6

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13187-021-01992-6

Keywords

Navigation